We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Europe's Contrast Media Market to Reach $915 Million in 2008

By HospiMedica staff writers
Posted on 23 Oct 2002
Mediocre performance, sluggish growth, and a maturing market have affected Europe's contrast media industry, estimated at US$684 million in 2001, according to a new study by Frost & Sullivan (London, UK), the international marketing consulting company.

However, medical institutions are increasing imaging equipment installations that will continue to require the use of contrast media for imaging. Moreover, the growing number of these installations will increase patient throughput and the number of procedures performed. These factors will help push sales in the overall European contrast media market to $915 million in 2008, say Frost & Sullivan analysts. The star performer in the contrast media arena is magnetic resonance imaging (MRI), whose rising popularity as a reliable imaging tool is stimulating innovation and will prompt the launch of new MRI contrast agents.

Aiding this development is the defection from conventional x-ray modality, which will also have a favorable effect on computed tomography (CT) contrast media. However, MRI and ultrasound will be encroaching on the use of CT/x-ray, reducing their sector's share to 60.7% of the market in 2008. The price-sensitive nature of the market, caused by price erosion and saturation of the x-ray segment, is curtailing growth.

The contrast media industry's fortunes are linked to the performance of the medical imaging equipment market. "The penetration of medical imaging equipment will fuel demand for contrasting agents. Since many parts of Europe remain untapped by the imaging equipment industry, there are significant opportunities for increasing the installed base,” noted Sumit Sharma, research analyst at Frost & Sullivan.

CT has experienced the highest volume of procedures using contrast agents. Almost 12.2 million CT procedures were performed in Europe in 2001. Contributing to market saturation is the fact that some new imaging technologies completely minimize the use of contrast agents. Frost & Sullivan believes there will be a closer working environment between the contrast media industry and the imaging equipment industry in order to develop new contrast agents complementary to new technology-driven imaging equipment.




Related Links:
Frost & Sullivan
Multi-Use Ultrasound Table
Clinton
Breast Localization System
MAMMOREP LOOP
High-Precision QA Tool
DEXA Phantom
Mammo DR Retrofit Solution
DR Retrofit Mammography

Channels

Nuclear Medicine

view channel
Image: CXCR4-targeted PET imaging reveals hidden inflammatory activity (Diekmann, J. et al., J Nucl Med (2025). DOI: 10.2967/jnumed.125.270807)

PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack

Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.